Search details
1.
Immunogenicity of 2 and 3 Doses of the Quadrivalent Human Papillomavirus Vaccine up to 120 Months Postvaccination: Follow-up of a Randomized Clinical Trial.
Clin Infect Dis
; 71(4): 1022-1029, 2020 08 14.
Article
in English
| MEDLINE | ID: mdl-31617568
2.
Outcomes of invasive meningococcal disease in adults and children in Canada between 2002 and 2011: a prospective cohort study.
Clin Infect Dis
; 60(8): e27-35, 2015 Apr 15.
Article
in English
| MEDLINE | ID: mdl-25605282
3.
The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012.
Clin Infect Dis
; 59(9): 1208-15, 2014 Nov 01.
Article
in English
| MEDLINE | ID: mdl-25069868
4.
Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation.
BMC Public Health
; 14: 442, 2014 May 12.
Article
in English
| MEDLINE | ID: mdl-24884433
5.
Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.
JAMA
; 309(17): 1793-802, 2013 May 01.
Article
in English
| MEDLINE | ID: mdl-23632723
6.
Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v).
J Infect Dis
; 206(12): 1852-61, 2012 Dec 15.
Article
in English
| MEDLINE | ID: mdl-22872731
7.
Cost effectiveness of infant vaccination for rotavirus in Canada.
Can J Infect Dis Med Microbiol
; 23(2): 71-7, 2012.
Article
in English
| MEDLINE | ID: mdl-23730312
8.
Strategies for successful rapid trials of influenza vaccine.
Clin Trials
; 8(6): 699-704, 2011 Dec.
Article
in English
| MEDLINE | ID: mdl-21900340
9.
Optimizing Canadian public immunization programs: a prescription for action.
Can J Public Health
; 102(3): 193-5, 2011.
Article
in English
| MEDLINE | ID: mdl-21714317
10.
Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.
Clin Infect Dis
; 49(2): 205-12, 2009 Jul 15.
Article
in English
| MEDLINE | ID: mdl-19508165
11.
The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada.
Pediatr Infect Dis J
; 28(3): 220-4, 2009 Mar.
Article
in English
| MEDLINE | ID: mdl-19209096
12.
Epidemiology of pertussis and Haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b pediatric combination vaccine and an adolescent-adult tetanus-diphtheria-acellular pertussis vaccine: implications for disease prevention in the United States.
Pediatr Infect Dis J
; 28(6): 521-8, 2009 Jun.
Article
in English
| MEDLINE | ID: mdl-19436236
13.
Childhood immunization rates in Canada are too low: UNICEF.
Paediatr Child Health
; 19(5): 237-8, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24855424
14.
Will Infant Hepatitis B Immunization Protect Adults?
Pediatr Infect Dis J
; 38(6S Suppl 1): S64-S66, 2019 06.
Article
in English
| MEDLINE | ID: mdl-31205248
15.
Ongoing control of Haemophilus influenzae type B infections in Canadian children, 2004-2007.
Pediatr Infect Dis J
; 27(8): 755-7, 2008 Aug.
Article
in English
| MEDLINE | ID: mdl-18594482
16.
The epidemiology of children hospitalized with herpes zoster in Canada: Immunization Monitoring Program, Active (IMPACT), 1991-2005.
Pediatr Infect Dis J
; 27(2): 112-8, 2008 Feb.
Article
in English
| MEDLINE | ID: mdl-18174867
17.
How best to describe the risk of meningococcal B infection?
Paediatr Child Health
; 18(10): 543-4, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-24497782
18.
Effectiveness of pneumococcal conjugate vaccine in Greater Vancouver, Canada: 2004-2005.
Pediatr Infect Dis J
; 26(6): 540-2, 2007 Jun.
Article
in English
| MEDLINE | ID: mdl-17529875
19.
The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
Pediatr Infect Dis J
; 26(1): 31-5, 2007 Jan.
Article
in English
| MEDLINE | ID: mdl-17195702
20.
Immunologic considerations for the timing of the booster dose of 7-valent pneumococcal conjugate vaccine in young children.
Pediatr Infect Dis J
; 26(5): 387-92, 2007 May.
Article
in English
| MEDLINE | ID: mdl-17468647